This week’s ISMP featured newsletter article provides recommendations for preventing errors when pediatric patients need to be treated in settings that are not designated solely for children: https://www.ismp.org/node/82964
MSOS News
An International Medication Safety Network (IMSN) special interest group chaired by ISMP recently published recommendations for global implementation of safe oxytocin use practices: https://www.intmedsafe.net/imsn-oxytocin-sig-issues-recommendations-for-...
ISMP’s most recent featured newsletter article takes a closer look at oxytocin-related errors, including uncovering some new trends, and provides safe practice recommendations: https://www.ismp.org/node/80423
ISMP’s new online, interactive course offers healthcare organizations a standardized, cost-effective way to ensure staff involved in the medication use process have the basic knowledge they need to avoid risks and prevent errors. It is available through an annual organizational subscription. For more: https://www.ismp.org/educational-services-healthcare-organizations
Respondents to a recent ISMP survey indicated that strategic frameworks like California’s Medication Error Reduction Plan (MERP) can help reduce risk, increase reporting, and justify MSO and similar positions: www.ismp.org/node/75991